UAE Cardiac Surgery Instruments Market Report 2022 to 2030

UAE Cardiac Surgery Instruments Market Analysis

$ 3999

The UAE Cardiac Surgery Instruments Market is expected to witness growth from $10 Mn in 2022 to $19 Mn in 2030 with a CAGR of 7.60% for the forecasted year 2022-2030. The UAE has gained popularity as a destination for medical tourism, especially among patients seeking high-quality treatment at a lower cost. As a result, there is now greater demand for cardiac surgery instruments. The market is segmented by type, application and by end user. Some key players in this market include Gulf Scientific Al Mazroui Medical and Chemical Supplies, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.

ID: IN10AEMD004 CATEGORY: Medical Devices GEOGRAPHY: UAE AUTHOR: Jigyasu Bhandari

Buy Now

UAE Cardiac Surgery Instruments Healthcare Market Executive Analysis

The UAE Cardiac Surgery Instruments Market size is at around $10 Mn in 2022 and is projected to reach $19 Mn in 2030, exhibiting a CAGR of 7.60% during the forecast period. Healthcare costs in the UAE are present at $2,996.36 per person, up from $2,843.78 in 2018. The UAE's GDP will include 5.5% of healthcare spending in 2021. Male and female life expectancy statistics in the UAE are 78.21 and 80.99 years, respectively, in 2022.

In the United Arab Emirates (UAE), as in many other nations around the globe, cardiovascular disease (CVD) is a significant public health concern. In the UAE, CVD places first in terms of fatalities, accounting for about 30% of all fatalities. The UAE has a high incidence of CVD in part because of the predominance of risk factors for the disease, such as smoking, diabetes, obesity, and hypertension. As a matter of fact, the prevalence of hypertension in the UAE varies from 28% to 41%, while that of diabetes ranges from 14% to 25%. With rates varying from 25% to 37%, obesity is also very common in the UAE. Instruments used in cardiac surgery are used to identify and address heart and cardiovascular conditions like heart attacks, arrhythmias, and issues with heart valves. Both infants and adults who have congenital heart defects can receive treatment with them. When operating on delicate heart tissues and structures, it is crucial that the instruments used in cardiac surgery be precise and accurate. These tools help surgeons carry out procedures more precisely, lowering the possibility of complications and increasing patient outcomes. Instruments used in cardiac surgery are made to the greatest standards, guaranteeing their reliability and safety. This is essential for cardiac surgeries because there is very little room for error and mistakes can have severe repercussions.

UAE Cardiac Surgery Instruments Market Analysis

Market Dynamics

Market Growth Drivers

Particularly among patients looking for high-quality care at a cost that is reasonable, the UAE is increasing in attractiveness as a destination for medical tourism. As a result, there is currently higher demand for cardiac surgery, related medical procedures, and cardiac surgery instruments. Because of a population that is getting older and rising rates of risk factors like hypertension, diabetes, and obesity, cardiovascular illnesses are becoming more common in the United Arab Emirates. As a result, it is expected that the demand for heart surgery equipment will rise in the coming years. The creation of novel cardiac surgery tools and technologies is fueling market expansion in the UAE by enhancing the safety, efficacy, and precision of surgical procedures.

Market Restraints

The high cost of cardiac surgery instruments can be a major barrier to entry for some manufacturers in the UAE cardiac surgery equipment market. In especially those with limited funds, hospitals and clinics may find it difficult to purchase these instruments due to their high cost. The competition among manufacturers is expected to intensify as the market for cardiac surgery instruments in the UAE expands. Price pressure could result from this, making it harder for manufacturers to stand out from other manufacturers in the market.

Competitive Landscape

Key Players

Gulf Scientific (UAE)
Al Mazroui Medical and Chemical Supplies (UAE)
LivaNova
B. Braun
KLS Martin
Medline Industries
STILLE

Recent Notable Deals

October 2021: A 10-year strategic partnership agreement between Abu Dhabi Health Services Company and Siemens Healthineers was revealed. (SEHA). In accordance with the deal, Siemens Artis pheno robotic imaging system—used in cardiac surgeries—will be installed in three SEHA hospitals.

June 2022: In order to distribute its selection of cardiac surgery instruments to medical institutions all over the UAE, Abbott Laboratories announced a partnership with the distributor NMC Trading, headquartered in the UAE.

Healthcare Policies and Regulatory Landscape

The Ministry of Health and Prevention (MOHAP) and the Dubai Health Authority (DHA) are two government organizations that accomplish the UAE's well-established healthcare system. In the UAE, there is a strong supervisory agenda for cardiac surgery instruments, with laws and standards in place to promise patient safety and the calibre of medical devices. The Medical Device Single Audit Program (MDSAP) and ISO 13485 are two international standards for medical devices that the UAE has executed. To ensure that their products satisfy the necessary safety and quality standards, medical device manufacturers must adhere to these standards and endure routine audits. Before marketing their goods in the UAE, medical device manufacturers are required by the MOHAP and DHA to acquire regulatory approval. A dossier containing clinical data, performance and safety data, and details on the manufacturing process is usually submitted as part of the approval process. To guarantee adherence to regional regulations, the regulatory authorities also inspect manufacturing facilities directly. The UAE has also implemented a number of healthcare policies and initiatives, such as the Abu Dhabi Quality and Conformity Council and Dubai Healthcare City (DHCC), to further support patient safety and quality in healthcare (QCC). While QCC is in charge of creating and enforcing conformity plans and regulations for pharmaceuticals, medical devices, and other devices, DHCC is a free zone devoted to healthcare, research, and education.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Cardiac Surgery Instruments Market Segmentation

By Type (Revenue, USD Billion):

The market is divided into segments in this study based on the goods, applications, end users, and geographical areas. The market is divided into forceps, scissors, needle holders, clamps, and other cardiac surgery instruments based on the product. In 2017 the forceps category led the market, and it is anticipated that it will increase at the fastest rate going forward. The rise in heart surgeries and the frequent usage of forceps in most cardiac procedures are credited with the segment's strong growth.

Forceps
Vascular Forceps
Grasping Forceps
Other Forceps
Needle Holders
Scissors
Clamps
Other Cardiac Surgical Instruments

By Application (Revenue, USD Billion):

The market is further segmented by application into paediatric cardiac surgery, heart valve surgery, coronary artery bypass graft (CABG), and other applications. The UAE market's largest and fastest-growing application segment is CABG. This is mostly explained by the increased prevalence of heart illnesses and the consequent rise in surgical treatments. The second-largest category is heart valve surgery.

Coronary Artery Bypass Graft (CABG)
Heart Valve Surgery
Pediatric Cardiac Surgery
Other Applications

By End User (Revenue, USD Billion):

Based on the end user, the market is segmented into hospitals and cardiac centers, and ambulatory surgery centers. The hospitals and cardiac centers segment is expected to dominate the market for cardiac surgery instruments. Growth in this end-user segment can be attributed to the increasing incidence of cardiac and heart valve diseases and the subsequent increase in the number of cardiac surgery procedures.

Hospitals and Cardiac Centers
Ambulatory Surgery Centers

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.